Current Edition

Transparency: Turning Business Constraint into Commercial Advantage

The pharmaceutical industry, one of the most crucial in the world in terms of impact on the lives of patients – from relieving pain to conquering disease – is in the midst of significant initiatives to improve transparency and build stronger public trust. In the following Regulatory and Marketplace feature we are going to read about Transparency: Turning business constraint into commercial advantage, by Guillaume Roussel, Director of Strategy, Europe, Veeva Network, Veeva Systems.